Curtis Coughlin II
Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 16 | 2026 | 375 | 4.220 |
Why?
| | Pyridoxine | 10 | 2024 | 37 | 2.860 |
Why?
| | Aldehyde Dehydrogenase | 9 | 2024 | 99 | 2.120 |
Why?
| | Neonatal Screening | 4 | 2024 | 178 | 1.980 |
Why?
| | Hyperglycinemia, Nonketotic | 8 | 2026 | 56 | 1.770 |
Why?
| | Lysine | 8 | 2024 | 302 | 1.600 |
Why?
| | Arginine | 4 | 2020 | 262 | 1.230 |
Why?
| | Urea Cycle Disorders, Inborn | 3 | 2026 | 26 | 1.140 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 3 | 2023 | 24 | 1.040 |
Why?
| | Pipecolic Acids | 4 | 2024 | 24 | 1.040 |
Why?
| | Brain Diseases, Metabolic | 2 | 2023 | 8 | 0.960 |
Why?
| | Disclosure | 4 | 2023 | 85 | 0.800 |
Why?
| | Genetic Counseling | 3 | 2023 | 81 | 0.760 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 2015 | 20 | 0.750 |
Why?
| | Vitamin B Complex | 2 | 2022 | 40 | 0.620 |
Why?
| | Infant, Newborn | 19 | 2024 | 6424 | 0.580 |
Why?
| | Dietary Supplements | 2 | 2020 | 575 | 0.570 |
Why?
| | Glycine | 4 | 2026 | 187 | 0.550 |
Why?
| | Mutation, Missense | 4 | 2016 | 340 | 0.550 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 4 | 0.490 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 6 | 0.490 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 13 | 0.490 |
Why?
| | Seizures | 4 | 2022 | 460 | 0.440 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.440 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.440 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 32 | 0.440 |
Why?
| | Brain Diseases | 2 | 2020 | 152 | 0.440 |
Why?
| | Genetic Testing | 6 | 2023 | 478 | 0.410 |
Why?
| | Metabolism, Inborn Errors | 2 | 2026 | 42 | 0.400 |
Why?
| | Humans | 56 | 2026 | 144261 | 0.400 |
Why?
| | Quality of Life | 1 | 2026 | 3166 | 0.400 |
Why?
| | Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2010 | 4 | 0.400 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 210 | 0.390 |
Why?
| | Hyperargininemia | 2 | 2018 | 2 | 0.370 |
Why?
| | Sudden Infant Death | 2 | 2010 | 39 | 0.370 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2021 | 35 | 0.370 |
Why?
| | Mitochondria | 2 | 2020 | 983 | 0.370 |
Why?
| | Glutaryl-CoA Dehydrogenase | 2 | 2023 | 5 | 0.370 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 226 | 0.350 |
Why?
| | Amino Acids | 1 | 2015 | 521 | 0.340 |
Why?
| | Biomarkers | 5 | 2024 | 4254 | 0.330 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.320 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2010 | 6 | 0.320 |
Why?
| | Mutation | 8 | 2020 | 4085 | 0.320 |
Why?
| | Urinary Tract | 1 | 2010 | 48 | 0.320 |
Why?
| | Sequence Deletion | 1 | 2010 | 193 | 0.310 |
Why?
| | Mosaicism | 1 | 2010 | 73 | 0.300 |
Why?
| | Muscular Diseases | 1 | 2010 | 108 | 0.300 |
Why?
| | Hirschsprung Disease | 1 | 2010 | 91 | 0.290 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 93 | 0.290 |
Why?
| | Primary Health Care | 1 | 2019 | 1710 | 0.290 |
Why?
| | Energy Metabolism | 1 | 2015 | 935 | 0.280 |
Why?
| | Male | 29 | 2026 | 72035 | 0.280 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1495 | 0.270 |
Why?
| | Diet Therapy | 2 | 2020 | 37 | 0.270 |
Why?
| | DNA Mutational Analysis | 4 | 2015 | 405 | 0.270 |
Why?
| | Infant | 17 | 2024 | 10022 | 0.250 |
Why?
| | Biological Ontologies | 1 | 2026 | 21 | 0.240 |
Why?
| | Tandem Mass Spectrometry | 2 | 2024 | 576 | 0.230 |
Why?
| | Liver | 3 | 2023 | 1884 | 0.230 |
Why?
| | Hypoglycemia | 2 | 2010 | 477 | 0.230 |
Why?
| | Arginase | 1 | 2015 | 27 | 0.230 |
Why?
| | 2-Aminoadipic Acid | 3 | 2024 | 7 | 0.230 |
Why?
| | Genetic Variation | 2 | 2015 | 982 | 0.230 |
Why?
| | Genetic Diseases, X-Linked | 2 | 2017 | 25 | 0.230 |
Why?
| | Phenotype | 7 | 2026 | 3157 | 0.220 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 44 | 0.220 |
Why?
| | Female | 26 | 2026 | 77976 | 0.220 |
Why?
| | Heterozygote | 4 | 2020 | 315 | 0.220 |
Why?
| | Cognition | 3 | 2022 | 1258 | 0.210 |
Why?
| | Longitudinal Studies | 4 | 2026 | 2926 | 0.210 |
Why?
| | Databases, Genetic | 1 | 2015 | 248 | 0.200 |
Why?
| | Child, Preschool | 15 | 2024 | 11774 | 0.200 |
Why?
| | Dried Blood Spot Testing | 1 | 2024 | 126 | 0.200 |
Why?
| | Glutarates | 1 | 2023 | 11 | 0.200 |
Why?
| | Rare Diseases | 2 | 2026 | 113 | 0.200 |
Why?
| | Counselors | 1 | 2023 | 14 | 0.200 |
Why?
| | Acidosis, Lactic | 3 | 2020 | 45 | 0.190 |
Why?
| | Genome, Human | 1 | 2015 | 422 | 0.190 |
Why?
| | Leigh Disease | 2 | 2020 | 22 | 0.190 |
Why?
| | Gene Expression | 2 | 2020 | 1487 | 0.190 |
Why?
| | Genotype | 2 | 2019 | 1833 | 0.190 |
Why?
| | Kidney | 1 | 2010 | 1495 | 0.190 |
Why?
| | Multienzyme Complexes | 2 | 2026 | 67 | 0.180 |
Why?
| | Hyperammonemia | 2 | 2016 | 18 | 0.180 |
Why?
| | Child | 17 | 2024 | 22537 | 0.180 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2359 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2026 | 487 | 0.180 |
Why?
| | Intellectual Disability | 2 | 2021 | 174 | 0.170 |
Why?
| | Self Report | 1 | 2026 | 863 | 0.170 |
Why?
| | Motor Disorders | 1 | 2021 | 17 | 0.170 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 8 | 0.170 |
Why?
| | Metabolism | 1 | 2021 | 44 | 0.170 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 13 | 0.170 |
Why?
| | Williams Syndrome | 1 | 2021 | 13 | 0.170 |
Why?
| | Communication | 3 | 2026 | 961 | 0.170 |
Why?
| | Chromosome Disorders | 1 | 2021 | 45 | 0.160 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 76 | 0.160 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 10 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 1087 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 106 | 0.160 |
Why?
| | International Cooperation | 1 | 2020 | 197 | 0.160 |
Why?
| | 22q11 Deletion Syndrome | 1 | 2019 | 3 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2022 | 234 | 0.150 |
Why?
| | Orphan Drug Production | 1 | 2019 | 5 | 0.150 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 48 | 0.150 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2019 | 46 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.150 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2917 | 0.150 |
Why?
| | Protein Subunits | 1 | 2020 | 226 | 0.150 |
Why?
| | Tryptophan | 1 | 2020 | 180 | 0.150 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2019 | 117 | 0.150 |
Why?
| | Fatal Outcome | 4 | 2016 | 307 | 0.140 |
Why?
| | Receptors, GABA-A | 1 | 2020 | 138 | 0.140 |
Why?
| | Corpus Callosum | 1 | 2019 | 72 | 0.140 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 149 | 0.140 |
Why?
| | Consensus | 1 | 2020 | 488 | 0.140 |
Why?
| | Chromosome Mapping | 1 | 2019 | 509 | 0.140 |
Why?
| | Argininosuccinic Aciduria | 1 | 2018 | 2 | 0.140 |
Why?
| | Citrullinemia | 1 | 2018 | 2 | 0.140 |
Why?
| | Adolescent | 8 | 2026 | 22281 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2020 | 2154 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 4 | 2020 | 3857 | 0.130 |
Why?
| | Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 1 | 0.130 |
Why?
| | Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2017 | 2 | 0.130 |
Why?
| | Orotate Phosphoribosyltransferase | 1 | 2017 | 3 | 0.130 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 10 | 0.130 |
Why?
| | Alleles | 2 | 2020 | 878 | 0.130 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 20 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 454 | 0.130 |
Why?
| | White Matter | 1 | 2019 | 151 | 0.130 |
Why?
| | Methylmalonic Acid | 1 | 2017 | 65 | 0.130 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 7 | 0.130 |
Why?
| | Bariatric Surgery | 1 | 2020 | 236 | 0.130 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 42 | 0.120 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 6 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2020 | 275 | 0.120 |
Why?
| | Point Mutation | 1 | 2017 | 243 | 0.120 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2017 | 77 | 0.120 |
Why?
| | Cohort Studies | 3 | 2022 | 5935 | 0.120 |
Why?
| | Sodium Benzoate | 1 | 2016 | 5 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2016 | 50 | 0.120 |
Why?
| | Dextromethorphan | 1 | 2016 | 23 | 0.120 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 107 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 31 | 0.110 |
Why?
| | Zebrafish | 1 | 2020 | 528 | 0.110 |
Why?
| | Portal Vein | 1 | 2016 | 114 | 0.110 |
Why?
| | Introns | 1 | 2016 | 254 | 0.110 |
Why?
| | Motor Activity | 1 | 2020 | 720 | 0.110 |
Why?
| | Aminoacylation | 1 | 2015 | 14 | 0.110 |
Why?
| | Informed Consent | 3 | 2023 | 198 | 0.110 |
Why?
| | Exons | 1 | 2016 | 358 | 0.110 |
Why?
| | Dyskinesias | 1 | 2015 | 20 | 0.110 |
Why?
| | Homocystinuria | 1 | 2015 | 62 | 0.110 |
Why?
| | Siblings | 1 | 2016 | 195 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 88 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1559 | 0.110 |
Why?
| | Cell Respiration | 1 | 2015 | 107 | 0.110 |
Why?
| | Electron Transport | 1 | 2015 | 118 | 0.110 |
Why?
| | Young Adult | 4 | 2026 | 13990 | 0.110 |
Why?
| | Sequence Alignment | 1 | 2015 | 366 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.100 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.100 |
Why?
| | Genetic Association Studies | 2 | 2020 | 372 | 0.100 |
Why?
| | Glutaredoxins | 1 | 2013 | 15 | 0.100 |
Why?
| | RNA, Transfer | 1 | 2015 | 144 | 0.100 |
Why?
| | Exome | 1 | 2015 | 227 | 0.100 |
Why?
| | Muscles | 1 | 2015 | 333 | 0.100 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 15 | 0.100 |
Why?
| | Genes, X-Linked | 1 | 2013 | 21 | 0.100 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.100 |
Why?
| | Time-to-Treatment | 1 | 2016 | 240 | 0.100 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2929 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2017 | 337 | 0.100 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 6 | 0.100 |
Why?
| | Osteoporosis | 1 | 2015 | 236 | 0.090 |
Why?
| | Vitamin B 12 | 1 | 2013 | 127 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 913 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1044 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1112 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 482 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 742 | 0.090 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 154 | 0.090 |
Why?
| | Brain | 3 | 2017 | 2930 | 0.080 |
Why?
| | Child Development | 1 | 2016 | 484 | 0.080 |
Why?
| | Ear | 1 | 2010 | 31 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 76 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 939 | 0.080 |
Why?
| | Adult | 5 | 2026 | 40262 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2012 | 464 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2010 | 304 | 0.070 |
Why?
| | Cystinuria | 1 | 2008 | 3 | 0.070 |
Why?
| | Penicillamine | 1 | 2008 | 18 | 0.070 |
Why?
| | Urinary Calculi | 1 | 2008 | 10 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 758 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2022 | 17009 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 1021 | 0.070 |
Why?
| | Middle Aged | 3 | 2026 | 35762 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2187 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 336 | 0.060 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2026 | 19 | 0.060 |
Why?
| | Transferases | 1 | 2026 | 27 | 0.060 |
Why?
| | Macaca fascicularis | 1 | 2015 | 71 | 0.060 |
Why?
| | National Library of Medicine (U.S.) | 1 | 2015 | 6 | 0.060 |
Why?
| | Decision Making | 2 | 2026 | 974 | 0.060 |
Why?
| | History, 21st Century | 1 | 2026 | 219 | 0.050 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2024 | 23 | 0.050 |
Why?
| | History, 20th Century | 1 | 2026 | 324 | 0.050 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1406 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2143 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1367 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2018 | 1129 | 0.040 |
Why?
| | United States | 4 | 2020 | 15876 | 0.040 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 9 | 0.040 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 50 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 464 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 37 | 0.040 |
Why?
| | Recommended Dietary Allowances | 1 | 2020 | 16 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2021 | 124 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 170 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 62 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 178 | 0.040 |
Why?
| | Chromosomal Instability | 1 | 2019 | 20 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 199 | 0.040 |
Why?
| | Public-Private Sector Partnerships | 1 | 2019 | 44 | 0.040 |
Why?
| | Drug Industry | 1 | 2019 | 48 | 0.040 |
Why?
| | Locomotion | 1 | 2020 | 105 | 0.040 |
Why?
| | Larva | 1 | 2020 | 242 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 93 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2019 | 139 | 0.040 |
Why?
| | Primates | 1 | 2019 | 131 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 354 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5813 | 0.030 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2019 | 322 | 0.030 |
Why?
| | Genetics | 1 | 2018 | 22 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2022 | 440 | 0.030 |
Why?
| | Animals | 4 | 2020 | 38030 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2021 | 281 | 0.030 |
Why?
| | Confidentiality | 1 | 2018 | 79 | 0.030 |
Why?
| | Ammonia | 1 | 2018 | 65 | 0.030 |
Why?
| | Citrulline | 1 | 2018 | 46 | 0.030 |
Why?
| | Glutamine | 1 | 2018 | 109 | 0.030 |
Why?
| | Orotic Acid | 1 | 2017 | 3 | 0.030 |
Why?
| | Anemia, Megaloblastic | 1 | 2017 | 9 | 0.030 |
Why?
| | Uridine | 1 | 2017 | 30 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2017 | 46 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 37 | 0.030 |
Why?
| | Autopsy | 1 | 2016 | 94 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1627 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1084 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 700 | 0.030 |
Why?
| | Intelligence Tests | 1 | 2016 | 56 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1046 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
| | Risk Factors | 1 | 2010 | 10699 | 0.030 |
Why?
| | Family | 1 | 2020 | 679 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2019 | 513 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 94 | 0.030 |
Why?
| | Homocysteine | 1 | 2015 | 151 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 181 | 0.030 |
Why?
| | Language | 1 | 2018 | 321 | 0.030 |
Why?
| | Methionine | 1 | 2015 | 162 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 275 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4556 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 832 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 247 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 369 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5988 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2879 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 252 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 200 | 0.020 |
Why?
| | Pyrimidines | 1 | 2017 | 532 | 0.020 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 13 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1487 | 0.020 |
Why?
| | Students | 1 | 2018 | 661 | 0.020 |
Why?
| | Age of Onset | 1 | 2013 | 536 | 0.020 |
Why?
| | Mental Disorders | 1 | 2021 | 1138 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 261 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 634 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 744 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1327 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 437 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2010 | 60 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1241 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2111 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7970 | 0.020 |
Why?
| | Mice | 1 | 2015 | 18329 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6021 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2270 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 4278 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4562 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2829 | 0.010 |
Why?
| | Diet | 1 | 2012 | 1271 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2603 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2730 | 0.010 |
Why?
|
|
Coughlin II's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|